Lifotronic(SH:688389)2022-04-15 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥209,986,012.08, representing a year-on-year increase of 27.70%[6] - The net profit attributable to shareholders was ¥67,142,229.55, reflecting a growth of 24.36% compared to the same period last year[6] - The net profit after deducting non-recurring gains and losses was ¥64,096,518.10, which is an increase of 30.27% year-on-year[6] - The net cash flow from operating activities reached ¥19,101,882.67, marking a significant increase of 36.30%[6] - Total operating revenue for Q1 2022 reached ¥209,986,012.08, a 27.7% increase from ¥164,431,677.50 in Q1 2021[33] - Net profit for Q1 2022 was ¥67,119,272.29, representing a 24.5% increase compared to ¥53,914,281.23 in Q1 2021[35] - Earnings per share for Q1 2022 were ¥0.16, compared to ¥0.13 in Q1 2021[39] - The company achieved a gross profit margin of approximately 34.0% in Q1 2022, compared to 28.5% in Q1 2021[35] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,507,836,656.90, up 2.26% from the end of the previous year[8] - Current assets totaled RMB 1,007,781,126.67, slightly down from RMB 1,010,296,053.05 year-over-year[28] - Total liabilities decreased to RMB 180,538,791.33 from RMB 216,501,445.41, a reduction of approximately 17%[31] - Non-current assets totaled RMB 500,055,530.23, up from RMB 464,157,528.20, indicating a growth of about 8%[28] - The total liabilities decreased slightly to CNY 323,547,130.45 in Q1 2022 from CNY 327,021,998.91 in Q1 2021[56] Shareholder Equity - The equity attributable to shareholders increased to ¥1,324,801,093.53, reflecting a growth of 5.53% compared to the previous year[8] - Total equity attributable to shareholders of the parent company rose to ¥1,324,801,093.53, up from ¥1,255,432,406.54 year-over-year[33] - The total equity increased to CNY 1,164,498,065.71 in Q1 2022, up from CNY 1,126,904,841.13 in Q1 2021, indicating a growth of 3.3%[56] Research and Development - Research and development expenses totaled ¥32,407,422.98, accounting for 15.43% of operating revenue, a decrease of 0.61 percentage points from the previous year[8] - Research and development expenses for Q1 2022 totaled ¥32,407,422.98, an increase of 22.9% from ¥26,376,152.52 in Q1 2021[35] - Research and development expenses increased to CNY 20,856,230.29 in Q1 2022, compared to CNY 18,178,120.52 in Q1 2021, reflecting a growth of 14.7%[56] Cash Flow - The company reported a net increase of 36.30% in cash flow from operating activities, attributed to increased sales collections[17] - Cash flow from operating activities in Q1 2022 was ¥235,388,345.29, compared to ¥173,049,325.57 in Q1 2021, indicating a significant increase[39] - Cash flow from investing activities was negative at -$114,428,706.36, an improvement from -$177,461,478.79 in the prior year[45] - Cash flow from financing activities resulted in a net outflow of -$1,539,297.38, compared to a net outflow of -$2,339,297.38 previously[45] Market and Product Development - The company has no new product launches or technological developments mentioned in the report[24] - There are no significant market expansion or acquisition strategies outlined in the current report[24] Accounting and Compliance - The company has implemented new accounting standards starting from 2022, affecting the financial statements from the beginning of the year[61] - The financial report is not applicable for the first-time execution of the new accounting standards[61] - The announcement indicates a transition to new accounting practices, which may impact future financial disclosures[61] - The company aims to enhance transparency and compliance with the updated accounting regulations[61]